Stock research on global mid-cap companies

Evaluate Research

Evaluate Research provides institutional quality stock research on small-cap and  mid-cap companies on a global basis, thus helping connect investors with the company.

At Evaluate Research, we provide free of cost to all investors a 20-25 page Initiation Report which evaluates in great detail all aspects of the company:  growth opportunities, catalysts, business description, competitive positioning, SWOT analysis, risks, etc.  In addition, we determine specific price targets for the company based on detailed 5-year complete forecasts of financial statements including IS, BS, CF, ratios, etc.  Finally, whereas many sell-side brokers offer sketchy and irregular ongoing maintenance research of companies, if not outright dropped or termination of coverage, at Evaluate Research we systematically monitor and regularly publish Update Notes covering quarterly earnings, major corporate events, etc.

All of the research reports are broadly and freely disseminated globally to leading Fund Managers and analysts who invest specifically in mid-size equities, and also on leading investment information platforms including: Bloomberg, Thomson Reuters, FactSet etc.

Stock research on global mid-cap companies, Evaluate Research

Equity Bottom-Up

<p>Revenue for 3Q 2016 increased 3.3% YoY to SG$ 49.7 million as compared to SG$ 48.1 million during 3Q 2015. The increase in revenue came on the back of strong performance from the healthcare segment and improvement in the occupancy rate in the property segment. This increase was partially offset by the 77% decrease in revenue from the leisure segment.</p>
<p>The company reported solid gross margin of 65.1% during the quarter as against 59.6% during 3Q 2015 as the margin of healthcare segment increased further. Other income which mainly includes dividend income from available-for-sale financial assets increased 15.7% to $26.2 million mainly due to the absence of one-off loss on disposal of available-for-sale financial assets in the prior year period. The increase in gross margin and other income helped the company to improve its net profits from SG$ 34.9 million in 3Q 2015 to SG$ 42.4 million in 3Q 2016, an increase of 21.3% YoY.</p>

Revenue for 3Q 2016 increased 3.3% YoY to SG$ 49.7 million as compared to SG$ 48.1 million during 3Q 2015. The increase in revenue came on the back of strong performance from the healthcare segment and improvement in the occupancy rate in the property segment. This increase was partially offset by the 77% decrease in revenue from the leisure segment.
The company reported solid gross margin of 65.1% during the quarter as against 59.6% during 3Q 2015 as the margin of healthcare segment increased further. Other income which mainly includes dividend income from available-for-sale financial assets increased 15.7% to $26.2 million mainly due to the absence of one-off loss on disposal of available-for-sale financial assets in the prior year period. The increase in gross margin and other income helped the company to improve its net profits from SG$ 34.9 million in 3Q 2015 to SG$ 42.4 million in 3Q 2016, an increase of 21.3% YoY.

Haw Par Corp

Haw Par Corp: 3QFY2016 Earnings Update